An average trading volume for Satsuma Pharmaceuticals Inc. (STSA) has been steady over the recent period.

The price of Satsuma Pharmaceuticals Inc. (NASDAQ: STSA) closed at $0.72 in the last session, up 10.40% from day before closing price of $0.65. In other words, the price has increased by $+0.0676 from its previous closing price. On the day, 4702434 shares were traded. STSA stock price reached its highest trading level at $0.7400 during the session, while it also had its lowest trading level at $0.6301.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



We take a closer look at STSA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.10 and its Current Ratio is at 10.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On August 31, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $16.

Mizuho Upgraded its Neutral to Buy on June 22, 2021, whereas the target price for the stock was revised from $7 to $15.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 15 when Leonard Braden Michael bought 831,694 shares for $0.63 per share. The transaction valued at 525,663 led to the insider holds 6,440,000 shares of the business.

Leonard Braden Michael bought 5,608,306 shares of STSA for $3,868,609 on Nov 14. The 10% Owner now owns 5,608,306 shares after completing the transaction at $0.69 per share. On Nov 14, another insider, COMMODORE CAPITAL LP, who serves as the 10% Owner of the company, sold 3,250,000 shares for $0.71 each. As a result, the insider received 2,294,500 and left with 461,286 shares of the company.

Stock Price History:

Over the past 52 weeks, STSA has reached a high of $8.08, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is 5.2095, while the 200-Day Moving Average is calculated to be 4.5557.

Shares Statistics:

According to the various share statistics, STSA traded on average about 621.60K shares per day over the past 3-months and 3.21M shares per day over the past 10 days. A total of 31.86M shares are outstanding, with a floating share count of 27.93M. Insiders hold about 9.98% of the company’s shares, while institutions hold 74.40% stake in the company. Shares short for STSA as of Oct 13, 2022 were 462.82k with a Short Ratio of 0.52M, compared to 251.78k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.47% and a Short% of Float of 2.95%.

Earnings Estimates

The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.54 for the current quarter, with a high estimate of -$0.52 and a low estimate of -$0.57, while EPS last year was -$0.42. The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.28 and low estimates of -$0.59.

Analysts are recommending an EPS of between -$1.85 and -$2.15 for the fiscal current year, implying an average EPS of -$1.98. EPS for the following year is -$1.47, with 5 analysts recommending between -$0.8 and -$2.55.